Literature DB >> 31061541

Synthesis of Leu-Enkephalin Peptidomimetics Containing Trifluoromethylalkenes as Amide Isopolar Mimics.

Venkateswararao Eeda1, Manikandan Selvaraju1, Ryan A Altman1.   

Abstract

Fluorinated peptidomimetics are valuable substrates for exploring peptide backbone conformations and for perturbing physicochemical properties of probe compounds. However, in some cases synthetic limitations restrict installation of the fluorinated peptidomimetics into the desired probe compounds. For instance, trifluoromethylalkenes have served as amide isopolar mimics, but are rarely utilized, because many standard peptide-coupling conditions promote the isomerization of the alkene to thermodynamically favored positions. To address this challenge, we report the conversion of a naturally occurring amino acid to a Tyr1-ψ/[CF3C=CH]-Gly2 dipeptide mimetic, and notably, successful peptide coupling reactions that avoid alkene isomerization. Using this strategy, we generated trifluoromethylalkene-containing Leu-enkephalin peptidomimetics in high purity and good yield. This sequence suggests that the trifluoromethylalkene peptidomimetics can be incorporated into other target molecules with appropriate optimization.

Entities:  

Keywords:  Leu-Enkephalin; Peptide coupling; Peptidomimetics; Trifluoromethylalkene; Trifluoromethylation

Year:  2018        PMID: 31061541      PMCID: PMC6499489          DOI: 10.1016/j.jfluchem.2018.12.005

Source DB:  PubMed          Journal:  J Fluor Chem        ISSN: 0022-1139            Impact factor:   2.050


  26 in total

1.  Methyl- and (Trifluoromethyl)alkene Peptide Isosteres: Synthesis and Evaluation of Their Potential as beta-Turn Promoters and Peptide Mimetics.

Authors:  Peter Wipf; Todd C. Henninger; Steven J. Geib
Journal:  J Org Chem       Date:  1998-09-04       Impact factor: 4.354

2.  Application of the Dakin-West reaction for the synthesis of oxazole-containing dual PPARalpha/gamma agonists.

Authors:  Alexander G Godfrey; Dawn A Brooks; Lynne A Hay; Mary Peters; James R McCarthy; David Mitchell
Journal:  J Org Chem       Date:  2003-04-04       Impact factor: 4.354

Review 3.  Peptides and peptidomimetics in medicine, surgery and biotechnology.

Authors:  Luca Gentilucci; Alessandra Tolomelli; Federico Squassabia
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 4.  Endogenous opiates and behavior: 2005.

Authors:  Richard J Bodnar; Gad E Klein
Journal:  Peptides       Date:  2006-09-12       Impact factor: 3.750

5.  3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT): a new coupling reagent with remarkable resistance to racemization.

Authors:  H Li; X Jiang; Y H Ye; C Fan; T Romoff; M Goodman
Journal:  Org Lett       Date:  1999-07-15       Impact factor: 6.005

6.  Convenient synthesis of alpha-trifluoromethylated acyloins from alpha-hydroxy or alpha-amino acids.

Authors:  M Kawase; S Saito; T Kurihara
Journal:  Chem Pharm Bull (Tokyo)       Date:  2000-09       Impact factor: 1.645

7.  Electrostatic versus steric effects in peptidomimicry: synthesis and secondary structure analysis of gramicidin S analogues with (E)-alkene peptide isosteres.

Authors:  Jingbo Xiao; Bernard Weisblum; Peter Wipf
Journal:  J Am Chem Soc       Date:  2005-04-27       Impact factor: 15.419

8.  Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using coumarinic acid and phenylpropionic acid linkers.

Authors:  B Wang; K Nimkar; W Wang; H Zhang; D Shan; O Gudmundsson; S Gangwar; T Siahaan; R T Borchardt
Journal:  J Pept Res       Date:  1999-04

9.  The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides.

Authors:  O S Gudmundsson; S D Jois; D G Vander Velde; T J Siahaan; B Wang; R T Borchardt
Journal:  J Pept Res       Date:  1999-04

10.  Optimizing oral absorption of peptides using prodrug strategies.

Authors:  R T Borchardt
Journal:  J Control Release       Date:  1999-11-01       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.